Director Ji Xiaodong files Form 3 for China SXT (SXTC)

Rhea-AI Filing Summary

China SXT Pharmaceuticals, Inc. director Ji Xiaodong has filed an initial Form 3, which is the required statement of beneficial ownership when someone becomes a company insider. The provided data shows no reported transactions, no listed holdings, and no derivative positions associated with this filing.

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"reporting person Ji Xiaodong is identified as a director in the filing"

beneficial ownership financial

"Form 3 is the initial statement of beneficial ownership for an insider"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ji Xiaodong

(Last) (First) (Middle)

NO.208, JINWAN VILLAGE

ZHOUZHUANG TOWN

(Street)

JIANGYIN JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/22/2021

3. Issuer Name and Ticker or Trading Symbol
China SXT Pharmaceuticals, Inc. [ SXTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Xiaodong Ji	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does China SXT Pharmaceuticals (SXTC) Form 3 report for Ji Xiaodong?

The Form 3 shows that Ji Xiaodong is a director of China SXT Pharmaceuticals. It serves as an initial statement of beneficial ownership. In the provided data, there are no reported transactions, no holding entries, and no derivative positions listed for this insider.

Does the SXTC Form 3 show any insider buying or selling by Ji Xiaodong?

No, the Form 3 data shows no insider buying or selling. All transaction counters, including buyCount, sellCount, acquireCount, and disposeCount, are zero. The transactions list is empty, indicating no trades are reported in connection with this initial ownership filing.

What role does Ji Xiaodong have at China SXT Pharmaceuticals (SXTC)?

According to the Form 3 data, Ji Xiaodong is a director of China SXT Pharmaceuticals. The filing flags is_director as 1 and shows no officer role or ten percent owner status, meaning he is reported solely in his capacity as a board director in this filing.

Does the China SXT (SXTC) Form 3 disclose any derivative securities for Ji Xiaodong?

No, the Form 3 data shows no derivative securities for Ji Xiaodong. The derivativeSummary section is empty and derivativeTransactionCount is zero, indicating there are no options, warrants, or other derivative positions reported in connection with this initial ownership statement.

What is the overall transaction direction in the SXTC Form 3 for Ji Xiaodong?

The overall transaction direction is neutral. The transactionSummary lists netBuySellShares as zero and netBuySellDirection as "neutral", with all buy, sell, and other transaction counts at zero, reflecting that no trades are associated with this Form 3 filing.